🇺🇸 FDA
Patent

US 11806389

Compositions and methods for treating central nervous system injury

granted A61KA61K2039/505A61K38/1709

Quick answer

US patent 11806389 (Compositions and methods for treating central nervous system injury) held by The United States Government as Represented by The Department of Veteran Affairs expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States Government as Represented by The Department of Veteran Affairs
Grant date
Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/505, A61K38/1709, A61K38/1725, A61K38/49